|
 |
| |
 |
|
|
|
|
| |
Board of Directors
|
|
 |
Joseph Klein, III |
|
| |
Managing Director, Gauss Capital Advisors, LLC.
Joseph Klein, III was elected to BioMarin's board
of directors in June 2005. Mr. Klein is currently
Managing Director of Gauss Capital Advisors, LLC,
a financial consulting and investment advisory firm
focused on biopharmaceuticals, which he founded
in March 1998. In addition to his investment advisory
and financial consulting activities, Mr. Klein currently
serves as a Venture Partner of Red Abbey Venture
Partners, LP, a life sciences private equity fund.
From September 2001 to September 2002, Mr. Klein
was a Venture Partner of MPM Capital, a healthcare
venture capital firm. From June 1999 to September
2000 when it merged with WebMD Corporation, Mr.
Klein served as Vice President, Strategy for Medical
Manager Corporation, a leading developer of physician
office management information systems. Mr. Klein
serves on the board of directors of three publicly
held biotechnology companies: Genaissance Pharmaceuticals,
Inc., Guilford Pharmaceuticals, Inc. and NPS Pharmaceuticals,
Inc.; as well as two private health care companies:
Keel Pharmaceuticals, Inc. and the Maryland Medical
Research Institute. Mr. Klein received a B.A. summa
cum laude in economics from Yale University, where
he was elected to Phi Beta Kappa, and an M.B.A.
from the Stanford Graduate School of Business.
|
|
| |
|
|
|
|
|
